Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: An example of nongenomic signaling
被引:89
作者:
Gardner, OS
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Pharmacol, Curriculum Toxicol, Chapel Hill, NC 27599 USAUniv N Carolina, Dept Pharmacol, Curriculum Toxicol, Chapel Hill, NC 27599 USA
Gardner, OS
[1
]
Dewar, BJ
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Pharmacol, Curriculum Toxicol, Chapel Hill, NC 27599 USAUniv N Carolina, Dept Pharmacol, Curriculum Toxicol, Chapel Hill, NC 27599 USA
Dewar, BJ
[1
]
Graves, LM
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Pharmacol, Curriculum Toxicol, Chapel Hill, NC 27599 USAUniv N Carolina, Dept Pharmacol, Curriculum Toxicol, Chapel Hill, NC 27599 USA
Graves, LM
[1
]
机构:
[1] Univ N Carolina, Dept Pharmacol, Curriculum Toxicol, Chapel Hill, NC 27599 USA
Peroxisome proliferator-activated receptors (PPARs) are a subfamily of nuclear hormone receptors that function as ligand-activated transcription factors to regulate lipid metabolism and homeostasis. In addition to their ability to promote gene transcription in a PPAR-dependent manner, ligands for this receptor family have recently been shown to induce mitogen-activated protein kinase (MAPK) phosphorylation. It is noteworthy that the transcriptional changes induced by PPAR ligands can be separated into distinct PPAR- and MAPK-dependent signaling pathways, suggesting that MAPKs alone mediate some of the effects of PPAR agonists in a nongenomic manner. This review will highlight recent studies that elucidate the nongenomic mechanisms of PPAR ligand-induced MAPK phosphorylation. The potential relevance of MAPK signaling in PPAR biology is also discussed.